Illumina offers technologies designed to make genetic analysis accessible to everyone. Using powerful, proven Illumina next-generation sequencing (NGS) and microarray solutions, researchers can read and understand genetic variations at new depths, more easily and quickly than before, enabling a wide variety of genomics applications. As a result, discoveries that were unimaginable even a few years ago are now becoming routine.
Genotyping is a popular and effective way to screen for SNPs and structural variations across the genome. Illumina technology offers accuracy, reproducibility, and content selection flexibility.
Next-generation sequencing and microarrays enable cytogenomic analysis of chromosome aberrations for constitutional and cancer research.
Explore various quantitative trait locus analysis approaches that map genomic regions to traits of interest.
NGS enables researchers to discover CRISPR genome editing off-target effects, confirm gene knockouts, and assess the functional impact of edits.
With ultra-high throughput, scalability, and speed, NGS enables researchers to study biological systems at a level never before possible. Learn more about how NGS works.
Our high-density microarray technology increases genomic coverage for whole-genome genotyping; resolution for cytogenetics and CNV detection; and sample throughput for focused genotyping and methylation. Learn more about microarray technology.